Risk factors
Altimmune (ALT) risk factors
Item 1A of every Altimmune, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors61 risks10 new11 dropped14 reworded
Altimmune added substantial new risk disclosures regarding term loan debt covenants, trade tariffs, and AI-driven cybersecurity threats this year.
Filed Mar 06, 2026 - FY2024 10-K risk factors62 risks
Clinical-stage biotechnology company dependent on the success of its lead product candidate pemvidutide for obesity and MASH. Substantial operating losses and reliance on external financing to fund ongoing development and clinical trials. Heavy dependence on third-party manufacturers and contractors for clinical trials and supply chain.
Filed Feb 27, 2025